Las Vegas, USA, June 30, 2022 (GLOBE NEWSWIRE) -- Global Functional Electrical Stimulation Devices Market Anticipated to Grow at a CAGR of 8.2% from 2022-27 | DelveInsight
Functional Electrical Stimulation Devices market to witness a rise in growth due to factors such as the increasing prevalence of musculoskeletal disorders globally, and the acceptance of rising importance of pain management therapies. Also, technological innovation in product development and the entrance of key companies is anticipated to fuel the Functional Electrical Stimulation market in the upcoming years.
DelveInsight's Functional Electrical Stimulation Devices Market Insights and Forecast report provides the current and forecast Functional Electrical Stimulation Devices, upcoming innovations in the devices, individual market shares of the devices, challenges, drivers, and barriers, market trends, and key competitors in the Functional Electrical Stimulation Devices Market scenario.
Some of the essential takeaways from the Functional Electrical Stimulation Devices Market report:
- According to DelveInsight analysis, North America is expected to dominate the overall Functional Electrical Stimulation Devices Market during the forecasted period.
- Key Functional Electrical Stimulation Devices companies proactively working in the market include HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.
- As per DelveInsight estimates, the Global Functional Electrical Stimulation Devices market is anticipated to grow at a CAGR of 8.2% during the forecast period from 2022 to 2027.
- On September 21, 2020, Medline Industries, LP received FDA approval for Medline DeNovo 4Pro Electrical Stimulation Device intended to be used for muscle stimulation for urinary incontinence treatment, pain management, muscle strengthening, and training.
- On October 29, 2020, g.tec medical engineering GmbH received FDA approval for g.Estim FES, neuromuscular electronic stimulator indicated for use under medical supervision for adjunctive therapy in the treatment of medical diseases and conditions.
- On March 04, 2020, Bioness Inc. received FDA approval for L100 Go System intended to provide ankle dorsiflexion in adults with foot drop or muscle weakness related to upper motor neuron disease/injury (e.g., stroke, damage to pathways to the spinal cord).
- Intento SA, initiated a clinical trial to study the efficacy of “Self-modulated Functional Electrical Stimulation in Chronic Stroke Patients with Severe and Moderate Upper Limb Paresis (SM-FES)” in the year 2019. The trial is expected to get complete by December 2022.
To know the key highlights related, download Functional Electrical Stimulation Devices Market Sample Report
Functional Electrical Stimulation Devices Overview
Functional electrical stimulation is a treatment method in which low-level electrical impulses are applied to nerves or muscles to improve or restore muscle function. Functional electrical stimulation allows muscles that have been paralyzed or partially paralyzed by a stroke to move again. When using Functional electrical stimulation as a treatment after a stroke, an electrical current is applied to the skin over a nerve, or over the bulk of a muscle, which causes the muscle to contract.
Functional Electrical Stimulation Devices Market Insight
Geographically, the Global Functional Electrical Stimulation Devices market is studied for North America, Europe, Asia-Pacific, and the Rest of the World. In terms of revenue share, North America is expected to dominate the overall Functional Electrical Stimulation Devices market during the forecast period. This domination is owing to the rising prevalence of the targeted population such as stroke, cerebral palsy, and musculoskeletal disorders, among others. Additionally, the rising obese population in the region could also increase the risk of developing musculoskeletal disorders as well as stroke among the population, leading to an increased demand for Functional Electrical Stimulation Devices in the upcoming years. Moreover, the presence of key players in the region is one of the factors projected to drive the regional Functional Electrical Stimulation Devices market.
For instance, on September 21, 2020, Medline Industries, LP received FDA approval for Medline DeNovo 4Pro Electrical Stimulation Device intended to be used for muscle stimulation for urinary incontinence treatment, pain management, muscle strengthening, and training. The device is a TENS (Transcutaneous Electrical Nerve Stimulator), ETS (Electrical Muscle Stimulator), and NMES (Neuromuscular Electrical Stimulator also known as STIM) including FES (Functional Electrical Stimulation) with EMG biofeedback.
Learn more about the Key companies covered in the report by downloading @ Functional Electrical Stimulation Devices Market Assessment
Functional Electrical Stimulation Devices Market Dynamics
The major factor responsible for driving the demand for Functional Electrical Stimulation Devices is the rising prevalence of musculoskeletal disorders across the globe. Moreover, the rising importance of pain management therapies and technological innovation in product development is anticipated to boost the Functional Electrical Stimulation Devices market in the upcoming years. Other factors such as various research and development and clinical trials conducted by companies and research universities will also lead to a rise in Functional Electrical Stimulation Devices market growth. Lastly, key market expansion activities by the key manufacturers actively developing Functional Electrical Stimulation Devices to provide breakthrough rehabilitative care among the target population could also be a potential factor contributing to the growth of the Functional Electrical Stimulation Devices market during the upcoming years.
However, on the contrary, the risk associated with Functional Electrical Stimulation devices as well as the high cost of these devices is likely to impede the Functional Electrical Stimulation market growth. The unprecedented COVID-19 outbreak had a profound impact on the Functional Electrical Stimulation devices market. Owing to the lockdown restrictions posed during the COVID-19 pandemic, there were reduced patient visits and all other surgical procedures were temporarily paused, giving more attention to the COVID-19-inflicted patients. These all factors served as obstruction in the growth of the Functional Electrical Stimulation devices market.
To gain a better understanding of the COVID-19 impact on the Functional Electrical Stimulation Devices Industry, get a snapshot of the Functional Electrical Stimulation Devices Market Impact by COVID-19
Scope of the Functional Electrical Stimulation Devices Market Report
- Coverage: Global
- Study Period: 2019-2027
- Functional Electrical Stimulation Devices Market Segmentation By Product: Wired Devices And Wireless Devices
- Functional Electrical Stimulation Devices Market Segmentation By Indication: Neurological Disorders, Pain Management, Musculoskeletal Disorders, And Others
- Functional Electrical Stimulation Devices Market Segmentation By End-User: Hospitals & Clinics, Ambulatory Surgical Centers, And Others
- Functional Electrical Stimulation Devices Market Segmentation By Geography: North America, Europe, Asia-Pacific, Rest of the World (Middle East, Africa, and South America)
- Key Functional Electrical Stimulation Devices Companies: HASOMED GmbH, Restorative Therapies, Bioness Inc., Trulife, Otto Bock, Odstock Medical Limited, Hobbs Rehabilitation, MotoMed, Medline Industries, LP, g.tec medical engineering GmbH, and others.
- Porter’s Five Forces Analysis, Product Profiles, Case Studies, KOL's Views, Analyst's View
Delveinsight Analysis: The Global Functional Electrical Stimulation Devices Market will grow at a CAGR of 8.2% during the forecast period from 2022 to 2027.
Know more about which MedTech player is set to dominate the Functional Electrical Stimulation Devices market @ Key Functional Electrical Stimulation Devices Companies
Table of Contents
| 1 | Report Introduction |
| 2 | Executive summary |
| 3 | Regulatory and Patent Analysis |
| 4 | Functional Electrical Stimulation Devices Market Key Factors Analysis |
| 5 | Functional Electrical Stimulation Devices Market Porter’s Five Forces Analysis |
| 6 | COVID-19 Impact Analysis on Functional Electrical Stimulation Devices Market |
| 7 | Functional Electrical Stimulation Devices Market Layout |
| 8 | Functional Electrical Stimulation Devices Market Global Company Share Analysis – Key 3-5 Companies |
| 9 | Functional Electrical Stimulation Devices Company and Product Profiles |
| 10 | Project Approach |
| 11 | KOL Views |
| 12 | DelveInsight Capabilities |
| 13 | Disclaimer |
| 14 | About DelveInsight |
Gain rich insights about the latest Functional Electrical Stimulation Devices regulatory approvals @ Functional Electrical Stimulation Devices Regulatory Landscape And Patent Analysis
Related Reports
Tissue Heart Valves Market By Product Type, By Type, By End User, By Geography is expected to grow at a steady CAGR. The report delivers an in-depth understanding of Tissue Heart Valves and the historical and forecasted Tissue Heart Valves market trends, market drivers, market barriers and key companies involved such as Abbott, Boston Scientific Corporation, CryoLife, Edward Lifesciences Corporation, Medtronic, Sorin Group (LivaNova PLC), and others.
Transcatheter Heart Valve Replacement Devices Market
DelveInsight’s ‘Transcatheter Heart Valve Replacement Devices (THVR) Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of THVR and the historical and forecasted THVR market trends, market drivers, market barriers and key companies involved such as Edwards Lifesciences, Medtronic, Livanova plc, Abbott, Boston Scientific Corporation, CryoLife Inc, and others.
Congestive Heart Failure Treatment Devices Market
DelveInsight’s ‘Congestive Heart Failure Treatment Devices -Market Insights, Competitive Landscape and Market Forecast-2026’ report delivers an in-depth understanding of congestive heart failure treatment devices and the historical and forecasted congestive heart failure treatment devices market trends, market drivers, market barriers and key companies involved such as Abiomed, Medtronic, Abbott, Berlin Heart GmbH, Boston Scientific Corporation, HeartWare International, LivaNova PLC, and others.
Congenital Heart Defect Devices Market
DelveInsight’s ‘‘Congenital Heart Defect Devices-Market Insights, Competitive Landscape and Market Forecast-2026’' report delivers an in-depth understanding of ‘Congenital Heart Defect Devices and the historical and forecasted ‘Congenital Heart Defect Devices market trends, market drivers, market barriers and unmet medical needs to curate best of the opportunities.
Heart Pump Devices Market By Product, By Type, By Therapy, By End-User and By Geography is expected to grow at a steady CAGR. The report delivers an in-depth understanding of Heart Pump Devices and the historical and forecasted Heart Pump Devices market trends, market drivers, market barriers and key companies involved such as Abbott Laboratories, Abiomed, Teleflex Incorporated, SynCardia Systems, St. Jude Medical Inc, CARMAT, CorWave SA, Medtronic Inc, Terumo Heart.
Interested to know more about the breakthrough happenings? Take a look at the posts below
- How Will New Discoveries of Deep Brain Stimulation Devices Transform the Pharma Domain?
- Cardiac Monitoring Devices Market is Booming
- What Factors are Shaping the Trends in the Implantable Cardiac Monitors Market?
- Boston Scientific starts recruitment for the EkoSonic™ Endovascular System
About DelveInsight
DelveInsight is a leading Business Consultant, and Market Research firm focused exclusively on life sciences. It supports Pharma companies by providing comprehensive end-to-end solutions to improve their performance.
For more insights, visit Pharma, Healthcare, and Biotech News
